442 Shares in Synopsys, Inc. $SNPS Purchased by Investment Partners LTD.

Investment Partners LTD. acquired a new stake in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 442 shares of the semiconductor company’s stock, valued at approximately $227,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. ABN Amro Investment Solutions bought a new stake in shares of Synopsys in the 2nd quarter worth about $60,246,000. Smithfield Trust Co boosted its stake in shares of Synopsys by 40.3% during the second quarter. Smithfield Trust Co now owns 327 shares of the semiconductor company’s stock valued at $167,000 after purchasing an additional 94 shares during the period. Candriam S.C.A. increased its stake in Synopsys by 17.1% in the 2nd quarter. Candriam S.C.A. now owns 89,418 shares of the semiconductor company’s stock worth $45,845,000 after buying an additional 13,051 shares during the period. Impax Asset Management Group plc boosted its position in Synopsys by 28.0% in the 2nd quarter. Impax Asset Management Group plc now owns 618,415 shares of the semiconductor company’s stock valued at $315,663,000 after buying an additional 135,198 shares during the period. Finally, Calamos Advisors LLC purchased a new position in shares of Synopsys during the second quarter worth approximately $28,820,000. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Synopsys Price Performance

Shares of SNPS stock opened at $397.70 on Thursday. Synopsys, Inc. has a fifty-two week low of $365.74 and a fifty-two week high of $651.73. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.51 and a current ratio of 1.62. The firm has a market capitalization of $73.87 billion, a price-to-earnings ratio of 31.22, a PEG ratio of 5.02 and a beta of 1.10. The stock’s 50-day simple moving average is $463.30 and its 200-day simple moving average is $514.08.

Synopsys (NASDAQ:SNPSGet Free Report) last issued its quarterly earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.75 by ($1.45). Synopsys had a net margin of 31.04% and a return on equity of 10.82%. The company had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.77 billion. During the same quarter in the previous year, the company posted $3.43 EPS. The company’s revenue for the quarter was up 14.0% compared to the same quarter last year. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. As a group, equities analysts forecast that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Insider Transactions at Synopsys

In other news, Director Robert G. Painter bought 350 shares of the company’s stock in a transaction that occurred on Thursday, September 11th. The shares were purchased at an average price of $425.44 per share, for a total transaction of $148,904.00. Following the completion of the transaction, the director directly owned 2,291 shares in the company, valued at approximately $974,683.04. This represents a 18.03% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Shelagh Glaser sold 3,655 shares of the stock in a transaction on Friday, September 5th. The stock was sold at an average price of $609.77, for a total transaction of $2,228,709.35. Following the completion of the sale, the chief financial officer owned 15,317 shares in the company, valued at $9,339,847.09. The trade was a 19.27% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 30,894 shares of company stock valued at $16,760,783 over the last three months. Company insiders own 0.62% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have weighed in on SNPS. Bank of America reiterated an “underperform” rating and issued a $525.00 target price (down from $625.00) on shares of Synopsys in a report on Wednesday, September 10th. Morgan Stanley dropped their price objective on shares of Synopsys from $715.00 to $510.00 and set an “overweight” rating on the stock in a research note on Thursday, September 11th. Mizuho lowered their target price on Synopsys from $700.00 to $600.00 and set an “outperform” rating for the company in a report on Thursday, September 11th. Robert W. Baird reissued a “neutral” rating and issued a $535.00 price target (down from $670.00) on shares of Synopsys in a research report on Wednesday, September 10th. Finally, Needham & Company LLC decreased their price target on shares of Synopsys from $660.00 to $550.00 and set a “buy” rating for the company in a research report on Wednesday, September 10th. Nine analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Synopsys currently has an average rating of “Hold” and an average target price of $562.14.

View Our Latest Analysis on SNPS

About Synopsys

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Further Reading

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.